Long-Acting Bronchodilators With or Without Inhaled Steroids in COPD
Allan S. Brett
Abstract
Allan S. Brett
Abstract
Long-acting β-agonists (e.g., salmeterol, formoterol) or anticholinergics (e.g., tiotropium) are recommended initially for patients with chronic obstructive pulmonary disease who have persistent symptoms and require bronchodilator therapy. The addition of inhaled corticosteroids is recommended for patients with repeated exacerbations. In …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Long-acting β-agonists (e.g., salmeterol, formoterol) or anticholinergics (e.g., tiotropium) are recommended initially for patients with chronic obstructive pulmonary disease who have persistent symptoms and require bronchodilator therapy. The addition of inhaled corticosteroids is recommended for patients with repeated exacerbations. In …
Key concepts: Salmeterol, Medicine, Bronchodilator, Formoterol, COPD, Bronchodilator Agents, Tiotropium bromide, Pulmonary disease